Cargando…
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma
BACKGROUND: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare variant of malignant mesothelioma, representing 10–15% of malignant mesothelioma cases. The preferred therapeutic approach is cytoreductive surgery (CRS) accompanied by hyperthermic intraperitoneal chemotherapy (HIPEC); the role...
Autores principales: | Wang, Xiao, Katz, Sharyn, Miura, John, Karakousis, Giorgos, Roshkovan, Leonid, Walker, Suzanne, McNulty, Sally, Ciunci, Christine, Cengel, Keith, Langer, Corey J., Marmarelis, Melina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521908/ https://www.ncbi.nlm.nih.gov/pubmed/36174024 http://dx.doi.org/10.1371/journal.pone.0275187 |
Ejemplares similares
-
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database
por: Bou‐Samra, Patrick, et al.
Publicado: (2023) -
Multimodality imaging of Surgicel(®), an important mimic of post-operative complication in the thorax
por: Roshkovan, Leonid, et al.
Publicado: (2021) -
First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019) -
Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023) -
A 53-Year-Old Man Presents to the ED With Shortness of Breath, Cough, and Fever
por: Roshkovan, Leonid, et al.
Publicado: (2021)